These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 3962948
1. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood. Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y. Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948 [Abstract] [Full Text] [Related]
2. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers. Tsuchie H, Kurimura O, Tamura I, Shimase K, Kaneto E, Kurimura T, Tsuda F, Mayumi M. Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353 [Abstract] [Full Text] [Related]
3. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI. Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [Abstract] [Full Text] [Related]
7. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, Islam LN, Hassan MS. Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438 [Abstract] [Full Text] [Related]
8. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M. Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666 [Abstract] [Full Text] [Related]
9. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers]. Arnold W, Hess G, Dormeyer HH, Gahl G, Hoffmann HG, Knolle J, Schönborn H. Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595 [Abstract] [Full Text] [Related]
10. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand. Hopkirk N, Moyes CD, Lucas CR. N Z Med J; 2000 Apr 14; 113(1107):114-6. PubMed ID: 10834277 [Abstract] [Full Text] [Related]
11. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis]. Reichlin B, Stalder GA, Gudat F, Bianchi L, Froesner GG. Schweiz Med Wochenschr; 1982 Apr 12; 112(15):523-4. PubMed ID: 7079688 [Abstract] [Full Text] [Related]
12. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). Zacharakis GH, Koskinas J, Kotsiou S, Papoutselis M, Tzara F, Vafeiadis N, Archimandritis AJ, Papoutselis K. J Med Virol; 2005 Oct 12; 77(2):173-9. PubMed ID: 16121378 [Abstract] [Full Text] [Related]
17. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. Kao JH, Chen PJ, Lai MY, Chen DS. J Med Virol; 2004 Mar 12; 72(3):363-9. PubMed ID: 14748059 [Abstract] [Full Text] [Related]
18. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels. Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C. Turk J Gastroenterol; 2004 Mar 12; 15(1):14-20. PubMed ID: 15264116 [Abstract] [Full Text] [Related]
20. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers. Yap SF, Wong NW, Goh KL. Malays J Pathol; 1994 Jun 12; 16(1):57-62. PubMed ID: 16329577 [Abstract] [Full Text] [Related] Page: [Next] [New Search]